The role of socioeconomic stress in the risk for obesity and diabetes: potential new targets of treatment

Trayhurn, 2004, Adipokines: inflammation and pleiotropic role of white adipose tissue, Br J Nutr, 92, 347, 10.1079/BJN20041213 Dandona, 2004, Inflammation: the link between insulin resistance, obesity, and diabetes, Trends Immunol, 26, 4, 10.1016/j.it.2003.10.013 Hari, 2005, Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylthiamazole and associated with Hashimoto's autoimmune thyroiditis, Mol Endocrinol, 19, 1231, 10.1210/me.2004-0100 Sjoholm, 2006, Inflammation and the etiology of T2DM, Diabetes Metab Res Rev, 22, 4, 10.1002/dmrr.568 Song, 2006, Activation of toll-like receptor 4 is associated with insulin resistance in adipocytes, Biochem Biophys Res Commun, 346, 739, 10.1016/j.bbrc.2006.05.170 Trayhurn, 2005, Signaling role of adipose tissue: adipokines and inflammation in obesity, Soc Biochem Trans, 33, 1078, 10.1042/BST20051078 Nord, 2003 2004 Holben, 2004, Food insecurity in the United States: how it affects our patients, Am Fam Physician, 69;, 1058 Cohen, 2006, Socioeconomic stress is associated with stress hormones, Psychosom Med, 68, 414, 10.1097/01.psy.0000221236.37158.b9 Moles, 2006, Psychological stress affects energy balance in mice: modulation by social status, Psychoneuroendocrinology, 31, 623, 10.1016/j.psyneuen.2006.01.004 Bjorntorp, 2001, Do stress reactions cause abdominal obesity and comorbidities?, Obes Rev, 2, 73, 10.1046/j.1467-789x.2001.00027.x Kral, 2005, The pathogenesis of obesity: stress and brain-gut axis, Surg Obes Relat Dis, 1, 25, 10.1016/j.soard.2004.12.009 Tomlinson, 2004, 11β-hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response, Endocr Rev, 25, 831, 10.1210/er.2003-0031 Stewart, 2003, Tissue-specific Cushing's syndrome, 11β-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action, Eur J Endocrinol, 149, 163, 10.1530/eje.0.1490163 Rask, 2001, Tissue specific dysregulation of cortisol metabolism in human obesity, J Clin Endocrinol Metab, 86, 1418, 10.1210/jc.86.3.1418 Tomlinson, 2007, Inhibition of 11b-hydroxysteroid dehydrogenase type1 activity in vivo limits the glucocorticoid exposure to human adipose tissue and decreases lipolysis, J Clin Endocrinol Metab, 92, 857, 10.1210/jc.2006-2325 Wake, 2003, Local and systemic impact of transcriptional up-regulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity, J Clin Endocrinol Metab, 88, 3983, 10.1210/jc.2003-030286 Antanasov, 2006, Coffee inhibits the reactivation of glucocorticoids by 11β-hydroxysteroid type 1: a glucocorticoid connection in the antidiabetic action of coffee?, FEBS Lett, 580, 4081, 10.1016/j.febslet.2006.06.046 Whorwood, 1993, Licorice inhibits 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action, Endocrinology, 132, 2287, 10.1210/en.132.6.2287 Sandeep, 2005, Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone, Diabetes, 54, 872, 10.2337/diabetes.54.3.872 Tomlinson, 2002, Expression of 11β-hydroxysteroid dehydrogenase types in adipose tissue is increased in human obesity, J Clin Endocrinol Metab, 87, 5630, 10.1210/jc.2002-020687 Chicurel, 2000, Whatever happened to leptin?, Nature, 404, 538, 10.1038/35007253 Glasgow, 2000, Leptin and the adrenal gland, Eur J Clin Invest, 30, 39, 10.1046/j.1365-2362.2000.0300s3039.x Otero, 2006, Towards a pro-inflammatory and immunomodulatory emerging role of leptin, Rheumatology, 45, 944, 10.1093/rheumatology/kel157 Scarpace, 2005, Leptin resistance exacerbates diet-induced obesity and is associated with diminished signaling capacity in rats, Diabetologia, 48, 1075, 10.1007/s00125-005-1763-x Al-Daghri, 2007, Serum leptin and its relation to anthropomorphic measures of obesity in pre-diabetic Saudis, Cardiovasc Diabetol, 6, 18, 10.1186/1475-2840-6-18 Hukshorn, 2003, Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted overweight men, Am J Clin Nutr, 77, 771, 10.1093/ajcn/77.4.771 Ghingo, 2005, Ghrelin: more than a natural GH secretagogue and/or orexigenic factor, Clin Endocrinol (Oxf), 62, 1, 10.1111/j.1365-2265.2004.02160.x Cummings, 2006, Ghrelin and the short and long-term regulation of appetite and body weight, Physiol Behav, 89, 71, 10.1016/j.physbeh.2006.05.022 Higgins, 2007, Ghrelin: the peripheral hunger hormone, Ann Med, 39, 116, 10.1080/07853890601149179 Dimaraki, 2006, Role of endogenous ghrelin in growth hormone secretion, appetite regulation, and metabolism, Rev Endocrinol Metab Disord, 7, 237, 10.1007/s11154-006-9022-0 Barazzoni, 2007, Relationships between deacylated and acylated ghrelin and insulin sensitivity in metabolic syndrome, J Clin Endocrinol Metab, 92, 3935, 10.1210/jc.2006-2527 Koijima, 2005, Altered ghrelin and peptide YY response to meals in bulimia nervosa, Clin Endocrinol, 62, 74, 10.1111/j.1365-2265.2004.02176.x English, 2007, Metformin prolong the fall in plasma ghrelin concentrations in T2DM, Diabetes Metab Res Rev, 23, 299, 10.1002/dmrr.681 Ranke, 2005, Insulin–like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance, Trends Endocrinol Metab, 16, 190, 10.1016/j.tem.2005.03.011 Senn, 2003, Suppressor of cytokine signaling-3(SOCS-3), a potential mediator of IL-6-dependent insulin resistance in hepatocytes, J Biol Chem, 278, 13740, 10.1074/jbc.M210689200 Schmidt, 2006, Leptin incident in T2DM: risk or protection?, Diabetologia, 49, 2086, 10.1007/s00125-006-0351-z Fasshauer, 2004, Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor and Jak/Stat-signaling pathways in 3T3-L1 adipocytes, J Endocrinol, 181, 129, 10.1677/joe.0.1810129 Yang, 2005, Interleukin-6 a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo, J Hepatol, 43, 704, 10.1016/j.jhep.2005.02.048 Kohn, 2005, Is type 2 diabetes (DMII) an autoimmune-inflammatory disorder of the innate immune system?, Endocrinology, 146, 10.1210/en.2005-0920 McCall, 2007, Phenylmethimazole antagonism of toll-like receptor 4 (TLR4) signaling in 3T3L-1 adipocytes McCall K, et al. Phenylmethimazole (C10) inhibits free fatty acid activation of TLR4 signaling in adipocytes. (Submitted to J Endocrinol) Zozulinska, 2006, T2DM mellitus as inflammatory disease, Diabetes Res Clin Pract, 74, S12, 10.1016/j.diabres.2006.06.007